X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2657) 2657
Publication (56) 56
Book Chapter (14) 14
Book Review (11) 11
Dissertation (6) 6
Conference Proceeding (4) 4
Magazine Article (3) 3
Paper (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
α-glucosidase (1226) 1226
index medicus (1046) 1046
alpha-glucosidase (971) 971
α-glucosidase inhibitor (523) 523
chemistry, medicinal (502) 502
food science & technology (490) 490
glycoside hydrolase inhibitors (483) 483
alpha-glucosidases - metabolism (465) 465
biochemistry & molecular biology (460) 460
animals (431) 431
humans (416) 416
α-amylase (367) 367
diabetes (364) 364
alpha-glucosidase inhibitor (338) 338
chemistry, applied (328) 328
enzyme inhibitors - pharmacology (320) 320
glucosidase (309) 309
pharmacology & pharmacy (305) 305
glycoside hydrolase inhibitors - pharmacology (302) 302
rats (290) 290
antioxidant (282) 282
acarbose (281) 281
alpha-amylase (264) 264
α-glucosidase inhibition (263) 263
chemistry, organic (252) 252
glycoside hydrolase inhibitors - chemistry (252) 252
alpha-glucosidase inhibition (240) 240
male (240) 240
plant extracts - pharmacology (240) 240
molecular structure (237) 237
hypoglycemic agents - pharmacology (224) 224
plant extracts - chemistry (219) 219
enzyme inhibitors - chemistry (213) 213
alpha-glucosidase inhibitors (210) 210
amylase (209) 209
antioxidant activity (206) 206
antioxidants (201) 201
diabetes mellitus (201) 201
structure-activity relationship (199) 199
derivatives (197) 197
in-vitro (195) 195
inhibition (194) 194
α-glucosidase inhibitors (193) 193
plant sciences (192) 192
alpha-glucosidases - chemistry (191) 191
enzymes (191) 191
kinetics (186) 186
flavonoids (181) 181
hyperglycemia (176) 176
nutrition & dietetics (172) 172
molecular docking (171) 171
mice (170) 170
chemistry, multidisciplinary (163) 163
leaves (159) 159
inhibitors (156) 156
constituents (152) 152
glucose (144) 144
alpha-amylases - antagonists & inhibitors (143) 143
chemistry (141) 141
dose-response relationship, drug (141) 141
polyphenols (137) 137
extract (133) 133
extracts (133) 133
diabetes mellitus, type 2 - drug therapy (132) 132
type 2 diabetes (130) 130
hypoglycemic agents - chemistry (127) 127
molecular docking simulation (120) 120
postprandial hyperglycemia (120) 120
identification (114) 114
α-glucosidase inhibitory activity (114) 114
α‐glucosidase (112) 112
saccharomyces cerevisiae - enzymology (109) 109
amylases (107) 107
biotechnology & applied microbiology (107) 107
blood glucose - metabolism (106) 106
enzyme inhibitors - isolation & purification (106) 106
glycoside hydrolase inhibitors - isolation & purification (106) 106
hypoglycemic agents - therapeutic use (106) 106
acid (104) 104
analysis (103) 103
antioxidants - pharmacology (101) 101
organic chemistry (101) 101
inhibitory concentration 50 (94) 94
female (93) 93
glycoside hydrolase inhibitors - chemical synthesis (92) 92
insulin (89) 89
alpha-glucosidase inhibitory activity (84) 84
antioxidants - chemistry (83) 83
oxidative stress (83) 83
alpha-amylases - metabolism (82) 82
purification (82) 82
magnetic resonance spectroscopy (80) 80
biological evaluation (79) 79
plants (78) 78
plant leaves - chemistry (75) 75
plant extracts - isolation & purification (73) 73
phenolic-compounds (72) 72
blood glucose - drug effects (71) 71
integrative & complementary medicine (71) 71
agriculture, multidisciplinary (70) 70
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2577) 2577
Japanese (132) 132
Korean (35) 35
Chinese (20) 20
French (4) 4
German (1) 1
Spanish (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Process Biochemistry, ISSN 1359-5113, 02/2018, Volume 65, pp. 228 - 232
Fermented Nutrient Broth (FNB) was found to be a potential source of antidiabetic drugs in the previous report. Thus, FNB was employed to isolate the active... 
α–glucosidase inhibitor | Diabetes | Microbial conversion | Paenibacillus sp | ENGINEERING, CHEMICAL | NEWLY ISOLATED STRAIN | 1-DEOXYNOJIRIMYCIN | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | alpha-glucosidase inhibitor | BIOCHEMISTRY & MOLECULAR BIOLOGY | PURIFICATION | FERMENTATION | IDENTIFICATION
Journal Article
Biomedical Chromatography, ISSN 0269-3879, 02/2013, Volume 27, Issue 2, pp. 148 - 155
Journal Article
Journal Article
European Journal of Inorganic Chemistry, ISSN 1434-1948, 07/2019, Volume 2019, Issue 28, pp. 3270 - 3276
α‐Glucosidase inhibitors slow the digestion of carbohydrates and reduce blood sugar levels after meals. Recently, our experimental team found that... 
Polyoxometalates | Inhibitors | Enzyme kinetics | Molecular docking | α‐Glucosidase | DESIGN | MIMICS | ACIDS | TYROSINASE | CHEMISTRY, INORGANIC & NUCLEAR | CLUSTERS | alpha-Glucosidase | ACTIVITY IN-VITRO | COMPLICATIONS | PROTEINS | Carbohydrates | Transition metals | Phosphomolybdic acid | Glucosidase | Polyoxometallates | Substitutes | Hydrogen bonds | Chemical bonds | Inhibition | Meals
Journal Article
Journal Article
Diabetes, Obesity and Metabolism, ISSN 1462-8902, 08/2014, Volume 16, Issue 8, pp. 761 - 765
We assessed the efficacy and safety of sitagliptin compared with α‐glucosidase inhibitor (αGI) in 120 of Japanese patients with type 2 diabetes mellitus (T2DM)... 
type 2 diabetes | DPP‐IV inhibitor | sulphonylureas | α‐glucosidase inhibitor | randomized trial | Type 2 diabetes | Randomized trial | α-glucosidase inhibitor | Sulphonylureas | DPP-IV inhibitor | VOGLIBOSE | MONOTHERAPY | HYPERGLYCEMIA | DOUBLE-BLIND TRIAL | alpha-glucosidase inhibitor | ENDOCRINOLOGY & METABOLISM | MELLITUS | Glycated Hemoglobin A - analysis | Triazoles - adverse effects | Glycoside Hydrolase Inhibitors - adverse effects | Dipeptidyl-Peptidase IV Inhibitors - adverse effects | Dipeptidyl-Peptidase IV Inhibitors - therapeutic use | Humans | Middle Aged | Glycoside Hydrolase Inhibitors - therapeutic use | Male | Pyrazines - therapeutic use | Hypoglycemia - prevention & control | 1-Deoxynojirimycin - therapeutic use | Drug Therapy, Combination - adverse effects | Inositol - therapeutic use | Inositol - adverse effects | 1-Deoxynojirimycin - analogs & derivatives | Female | 1-Deoxynojirimycin - adverse effects | Sitagliptin Phosphate | Hypoglycemia - chemically induced | Triazoles - therapeutic use | Hypoglycemic Agents - therapeutic use | Hyperglycemia - prevention & control | Japan | Sulfonylurea Compounds - therapeutic use | Inositol - analogs & derivatives | Diabetes Mellitus, Type 2 - blood | Gastrointestinal Agents - therapeutic use | Pyrazines - adverse effects | Aged | Gastrointestinal Agents - adverse effects | Diabetes Mellitus, Type 2 - drug therapy | alpha-Glucosidases - metabolism | alpha-Glucosidases - chemistry
Journal Article
Journal Article